Found: 73
Select item for more details and to access through your institution.
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2024, v. 71, n. 1, p. 95, doi. 10.1165/rcmb.2023-0185OC
- By:
- Publication type:
- Article
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 2, p. 268, doi. 10.1002/art.42677
- By:
- Publication type:
- Article
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03143-2
- By:
- Publication type:
- Article
Vascular–Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 207, n. 11, p. 1498, doi. 10.1164/rccm.202109-2174OC
- By:
- Publication type:
- Article
Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 4, p. 665, doi. 10.3390/cells12040665
- By:
- Publication type:
- Article
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 12, p. 5227, doi. 10.1111/bcp.15436
- By:
- Publication type:
- Article
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2022, v. 67, n. 2, p. 215, doi. 10.1165/rcmb.2021-0332OC
- By:
- Publication type:
- Article
Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 8, p. 1387, doi. 10.1002/art.42111
- By:
- Publication type:
- Article
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15039-3
- By:
- Publication type:
- Article
Smooth muscle Rac1 contributes to pulmonary hypertension.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 13, p. 3418, doi. 10.1111/bph.15805
- By:
- Publication type:
- Article
Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 7, p. 1805, doi. 10.1093/cvr/cvab187
- By:
- Publication type:
- Article
Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-021-02709-2
- By:
- Publication type:
- Article
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 11, p. 784, doi. 10.3390/metabo11110784
- By:
- Publication type:
- Article
Cibler les ligands du récepteur de l'activine de type IIA pour traiter l'hypertension artérielle pulmonaire.
- Published in:
- Médecine Sciences, 2021, v. 37, n. 10, p. 839, doi. 10.1051/medsci/2021131
- By:
- Publication type:
- Article
Pulmonary hypertension associated with neurofibromatosis type 2.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 3, p. 1, doi. 10.1177/20458940211029550
- By:
- Publication type:
- Article
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 5, p. 1391, doi. 10.1093/cvr/cvaa200
- By:
- Publication type:
- Article
Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 5006, doi. 10.3390/ijms22095006
- By:
- Publication type:
- Article
Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3451, doi. 10.3390/ijms22073451
- By:
- Publication type:
- Article
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21961-3
- By:
- Publication type:
- Article
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2566, doi. 10.3390/ijms22052566
- By:
- Publication type:
- Article
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 2144, doi. 10.3390/ijms22042144
- By:
- Publication type:
- Article
Genetic Delivery and Gene Therapy in Pulmonary Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1179, doi. 10.3390/ijms22031179
- By:
- Publication type:
- Article
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1502, doi. 10.3390/ijms22031502
- By:
- Publication type:
- Article
Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 84, doi. 10.3390/cells10010084
- By:
- Publication type:
- Article
Dendritic Cells in Pulmonary Hypertension: Foot Soldiers or Hidden Enemies?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Purinergic Dysfunction in Pulmonary Arterial Hypertension.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1422, doi. 10.3390/cells9061422
- By:
- Publication type:
- Article
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1248, doi. 10.3390/jcm9051248
- By:
- Publication type:
- Article
Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 5, p. 885, doi. 10.1093/cvr/cvz308
- By:
- Publication type:
- Article
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 3, p. 686, doi. 10.1093/cvr/cvz153
- By:
- Publication type:
- Article
Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.
- Published in:
- Pulmonary Circulation, 2019, v. 9, n. 4, p. 1, doi. 10.1177/2045894019889775
- By:
- Publication type:
- Article
Lysyl oxidase—a possible role in systemic sclerosis–associated pulmonary hypertension: a multicentre study.
- Published in:
- Rheumatology, 2019, v. 58, n. 9, p. 1547, doi. 10.1093/rheumatology/kez035
- By:
- Publication type:
- Article
Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.
- Published in:
- FASEB Journal, 2019, v. 33, n. 3, p. 3670, doi. 10.1096/fj.201801659R
- By:
- Publication type:
- Article
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 2, p. 432, doi. 10.1093/cvr/cvy186
- By:
- Publication type:
- Article
Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 12, p. 4105, doi. 10.3390/ijms19124105
- By:
- Publication type:
- Article
Expression ectopique du récepteur membranaire de l'interleukine 6 dans l'hypertension artérielle pulmonaire.
- Published in:
- Médecine Sciences, 2018, v. 34, n. 10, p. 765, doi. 10.1051/medsci/2018201
- By:
- Publication type:
- Article
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1694-9
- By:
- Publication type:
- Article
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Update in Pulmonary Vascular Disease 2016 and 2017.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Update in Pulmonary Vascular Disease 2016 and 2017.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2018, v. 59, n. 1, p. 13, doi. 10.1164/rccm.201801-0062UP
- By:
- Publication type:
- Article
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 11, p. 2209, doi. 10.1002/art.40229
- By:
- Publication type:
- Article
Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vers de nouvelles cibles pour le traitement de l'hypertension artérielle pulmonaire: Importance des communications cellulaires.
- Published in:
- Biologie Aujourd'hui, 2016, v. 210, n. 2, p. 65, doi. 10.1051/jbio/2016010
- By:
- Publication type:
- Article
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 3, p. 342, doi. 10.1164/rccm.201410-1851OC
- By:
- Publication type:
- Article